Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Bilateral idiopathic optic neuritis in pregnancy.
Season of birth as a risk factor for multiple sclerosis in Brazil.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
Brain circuitry outside the synaptic cleft.
The effects of heat stress on physical functioning in persons with multiple sclerosis.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Falls and physical activity in persons with multiple sclerosis.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Baló's Concentric Sclerosis in Multiple Sclerosis.
Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
Moyamoya disease can masquerade as multiple sclerosis.
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
Functional-structural correlations in the afferent visual pathway in pediatric demyelination.
Pages
« first
‹ previous
…
259
260
261
262
263
264
265
266
267
…
next ›
last »